论文部分内容阅读
7月3日,复旦大学附属华东医院泌尿外科主任医师孙忠全教授在“第十届全国检验与临床学术会议暨2015年中国医师协会检验医师年会”上,就PSA在前列腺癌筛查中的医学价值及应用现状进行探讨,以期指导临床实践,提高前列腺癌患者检出率,改善患者生存质量。今年6月,中国国家卫生和计划生育委员会发布了《前列腺特异性抗原检测前列腺癌临床应用标准》,并将于2015年12月31日正式实施,将血清PSA检测的参考区间定为<4.0μg/L,推荐PSA检测用于前列
On July 3, Professor Sun Zhongquan, chief physician of urology at Huadong Hospital affiliated to Fudan University, gave a speech titled “PSA in Prostate Cancer Screening” at the 10th National Conference of Clinical Laboratory and Clinical Medicine and the 2015 Annual Meeting of Chinese Medical Physicians The medical value and application status are discussed in order to guide the clinical practice, improve the detection rate of patients with prostate cancer and improve the quality of life of patients. In June of this year, the Chinese National Commission on Health and Family Planning released the “Clinical Application of Prostate Specific Antigen to Detect Prostate Cancer” and will be implemented on December 31, 2015. The reference interval of serum PSA test will be set as <4.0μg / L, PSA testing is recommended for the forefront